Acetaminophen 300 mg / phenyltoloxamine citrate 20 mg / salicylamide 200 mg Oral Tablet [Cetazone]
RxNorm 1048499
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1048499 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: acetaminophen 300 mg / phenyltoloxamine citrate 20 mg / salicylamide 200 mg Oral Tablet [Cetazone].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Acetaminophen 300 mg / phenyltoloxamine citrate 20 mg / salicylamide 200 mg Oral Tablet [Cetazone]
(Atom ID: 12359899)
SY
Synonym (SY):
APAP 300 mg / Phenyltoloxamine citrate 20 mg / salicylamide 200 mg Oral Tablet [Cetazone]
(Atom ID: 3856972)
SY